8 [20] A. J. Webb, N. Patel, S. Loukogeorgakis et al., “Acute blood pressure lowering, vasoprotective, and antiplatelet properties of dietary nitrate via bioconversion to nitrite,” Hypertension, vol. 51, no. 3, pp. 784–790, 2008. [21] T. Sobko, C. Marcus, M. Govoni, and S. Kamiya, “Dietary nit- rate in Japanese traditional foods lowers diastolic blood press- ure in healthy volunteers,” Nitric Oxide, vol. 22, no. 2, pp. 136– 140, 2010. [22] W. C. Willett, “Diet and health: what should we eat?” Science, vol. 264, no. 5158, pp. 532–537, 1994. [23] K. J. Joshipura, F. B. Hu, J. E. Manson et al., “The eﬀect of fruit and vegetable intake on risk for coronary heart disease,” An- nals of Internal Medicine, vol. 134, no. 12, pp. 1106–1114, 2001. [24] K. J. Joshipura, A. Ascherio, J. E. Manson et al., “Fruit and vegetable intake in relation to risk of ischemic stroke,” JAMA, vol. 282, no. 13, pp. 1233–1239, 1999. [25] J. O. Lundberg, E. Weitzberg, J. A. Cole, and N. Benjamin, “Nitrate, bacteria and human health,” Nature Reviews Micro- biology, vol. 2, no. 7, pp. 593–602, 2004. [26] M. Feelisch, B. O. Fernandez, N. S. Bryan et al., “Tissue processing of nitrite in hypoxia: an intricate interplay of nitric oxide-generating and -scavenging systems,” The Journal of Bio- logical Chemistry, vol. 283, no. 49, pp. 33927–33934, 2008. [27] H. Bjo¨rne, J. Petersson, M. Phillipson, E. Weitzberg, L. Holm, and J. O. Lundberg, “Nitrite in saliva increases gastric mucosal blood ﬂow and mucus thickness,” The Journal of Clinical Investigation, vol. 113, no. 1, pp. 106–114, 2004. [28] E. Weitzberg, M. Hezel, and J. O. Lundberg, “Nitrate-nitrite- nitric oxide pathway: implications for anesthesiology and intensive care,” Anesthesiology, vol. 113, no. 6, pp. 1460–1475, 2010. [29] N. S. Bryan, B. O. Fernandez, S. M. Bauer et al., “Nitrite is a sig- naling molecule and regulator of gene expression in mamma- lian tissues,” Nature Chemical Biology, vol. 1, no. 5, pp. 290– 297, 2005. [30] P. Kleinbongard, A. Dejam, T. Lauer et al., “Plasma nitrite concentrations reﬂect the degree of endothelial dysfunction in humans,” Free Radical Biology and Medicine, vol. 40, no. 2, pp. 295–302, 2006. [31] B. Gago, J. O. Lundberg, R. M. Barbosa, and J. Laranjinha, “Red wine-dependent reduction of nitrite to nitric oxide in the stomach,” Free Radical Biology and Medicine, vol. 43, no. 9, pp. 1233–1242, 2007. [32] Y. Tang, H. Garg, Y. J. Geng, and N. S. Bryan, “Nitric oxi- de bioactivity of traditional Chinese medicines used for car- diovascular indications,” Free Radical Biology and Medicine, vol. 47, no. 6, pp. 835–840, 2009. [33] D. Yach, C. Hawkes, C. L. Gould, and K. J. Hofman, “The glo- bal burden of chronic diseases: overcoming impediments to prevention and control,” JAMA, vol. 291, no. 21, pp. 2616– 2622, 2004. [34] C. J. L. Murray and A. D. Lopez, “Alternative projections of mortality and disability by cause 1990–2020: global Burden of Disease Study,” The Lancet, vol. 349, no. 9064, pp. 1498–1504, 1997. [35] T. J. McMahon, J. S. Hood, J. A. Bellan, and P. J. Kadow- itz, “N(ω)-nitro-L-arginine methyl ester selectively inhibits pulmonary vasodilator responses to acetylcholine and bradykinin,” Journal of Applied Physiology, vol. 71, no. 5, pp. 2026–2031, 1991. [36] T. J. McMahon, J. S. Hood, and P. J. Kadowitz, “Pulmonary vasodilator response to vagal stimulation is blocked by N(ω)- nitro-L-arginine methyl ester in the cat,” Circulation Research, vol. 70, no. 2, pp. 364–369, 1992. Evidence-Based Complementary and Alternative Medicine [37] D. D. Rees, R. M. J. Palmer, R. Schulz, H. F. Hodson, and S. Moncada, “Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo,” British Journal of Pharmacology, vol. 101, no. 3, pp. 746–752, 1990. [38] A. J. North, K. S. Lau, T. S. Brannon et al., “Oxygen upregulates nitric oxide synthase gene expression in ovine fetal pulmonary artery endothelial cells,” American Journal of Physiology, vol. 270, no. 4, pp. L643–L649, 1996. [39] N. Kim, Y. Vardi, H. Padma-Nathan, J. Daley, I. Goldstein, and I. S. De Tejada, “Oxygen tension regulates the nitric oxide pathway. Physiological role in penile erection,” The Journal of Clinical Investigation, vol. 91, no. 2, pp. 437–442, 1993. [40] D. J. Lefer, “Myocardial protective actions of nitric oxide don- ors after myocardial ischemia and reperfusion,” New Horizons, vol. 3, no. 1, pp. 105–112, 1995. [41] G. Johnson, P. S. Tsao, and A. M. Lefer, “Cardioprotective eﬀects of authentic nitric oxide in myocardial ischemia with reperfusion,” Critical Care Medicine, vol. 19, no. 2, pp. 244– 252, 1991. [42] K. E. Loke, S. K. Laycock, S. Mital et al., “Nitric oxide modu- lates mitochondrial respiration in failing human heart,” Circu- lation, vol. 100, no. 12, pp. 1291–1297, 1999. [43] D. D. Thomas, X. Liu, S. P. Kantrow, and J. R. Lancaster, “The biological lifetime of nitric oxide: implications for the perivascular dynamics of NO and O2,” Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 1, pp. 355–360, 2001. [44] X. I. Ma, A. S. Weyrich, D. J. Lefer, and A. M. Lefer, “Dimin- ished basal nitric oxide release after myocardial ischemia and reperfusion promotes neutrophil adherence to coronary endo- thelium,” Circulation Research, vol. 72, no. 2, pp. 403–412, 1993. [45] A. J. Palazzo, S. P. Jones, W. G. Girod, D. C. Anderson, D. N. Granger, and D. J. Lefer, “Myocardial ischemia-reperfusion injury in CD18- and ICAM-1-deﬁcient mice,” American Jour- nal of Physiology, vol. 275, no. 6, part 2, pp. H2300–H2307, 1998. [46] U. Walter and S. Gambaryan, “Roles of cGMP/cGMP-depen- dent protein kinase in platelet activation,” Blood, vol. 104, no. 8, article 2609, 2004. [47] J. W. Calvert and D. J. Lefer, “Statin therapy and myocardial no-reﬂow,” British Journal of Pharmacology, vol. 149, no. 3, pp. 229–231, 2006. [48] J. Li, C. A. Bombeck, S. Yang, Y. M. Kim, and T. R. Billiar, “Nitric oxide suppresses apoptosis via interrupting caspase activation and mitochondrial dysfunction in cultured hepato- cytes,” The Journal of Biological Chemistry, vol. 274, no. 24, pp. 17325–17333, 1999. [49] Y. M. Kim, R. V. Talanian, and T. R. Billiar, “Nitric oxide inhibits apoptosis by preventing increases in caspase-3- like activity via two distinct mechanisms,” The Journal of Biological Chemistry, vol. 272, no. 49, pp. 31138–31148, 1997. [50] J. O. Lundberg and M. Govoni, “Inorganic nitrate is a possible source for systemic generation of nitric oxide,” Free Radical Biology and Medicine, vol. 37, no. 3, pp. 395–400, 2004. [51] A. R. Butler and M. Feelisch, “Therapeutic uses of inorganic nitrite and nitrate: from the past to the future,” Circulation, vol. 117, no. 16, pp. 2151–2159, 2008. [52] X. Liu, H. Ma, C. Li et al., “Sixty-one cases of angina pectoris due to coronary heart disease treated by external use of the Paste of Nitrum and Realgar Powder on Zhiyang (GV 9),” Journal of Traditional Chinese Medicine, vol. 22, no. 4, pp. 243– 246, 2002.